Evidence map›Paper›PMID 35306712›Full record

ReviewClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Burden of allergic disease among ethnic minority groups in high-income countries.

Christina J Jones, Priyamvada Paudyal, Robert M West, Adel H Mansur, Nicola Jay, Nick Makwana, Sarah Baker, Mamidipudi T Krishna

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  3. Asthma and Multimorbidity Amongst Ethnic Minority Groups in High Income Countries.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Review
  4. Understanding the experiences of South Asian adults' management of food allergy.The journal of allergy and clinical immunology. Global · 2026
    Article
  5. Review
  6. Article
  7. Socioeconomic deprivation performs equally to race in the Pediatric Asthma Risk Score.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  8. The role of food allergy-related worry and self-efficacy in explaining quality of life in caregivers of children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2025
    Article
  9. Article
  10. Observational
  11. Inequalities in Access to Specialist Allergy Services in the United Kingdom: A Report From the BSACI Registry for Immunotherapy (BRIT).Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Article
  12. Article
  13. Understanding Health Equity in Patient-Reported Outcomes.The journal of allergy and clinical immunology. In practice · 2024
    Review
  14. Article
  15. Management of IgE-mediated food allergy in the 21st century.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2023
    Review
  16. Article
  17. Article
  18. Burden of allergic disease among ethnic minority groups in high-income countries.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Christina J JonesSchool of Psychology, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK.ORCID 0000-0003-3672-6631
Priyamvada PaudyalDepartment of Primary Care & Public Health, Brighton & Sussex Medical School, Brighton, UK.
Robert M WestLeeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Adel H MansurBirmingham Regional Severe Asthma Service, University Hospitals Birmingham NHS Foundation Trust, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Nicola JaySheffield Children's Hospital NHS Foundation Trust, Sheffield, UK.
Nick MakwanaDepartment of Child Health, Sandwell and West Birmingham Hospitals, Birmingham, UK.
Sarah BakerAnaphylaxis Campaign, Farnborough, UK.
Mamidipudi T KrishnaDepartment of Allergy and Immunology, University Hospitals Birmingham NHS Foundation Trust, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust · GBBrighton and Sussex Medical School · GBRed Hat (United Kingdom) · GBSandwell & West Birmingham Hospitals NHS Trust · GBSheffield Children's NHS Foundation Trust · GBUniversity of Leeds · GBUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic raised acute awareness regarding inequities and inequalities and poor clinical outcomes amongst ethnic minority groups. Studies carried out in North America, the UK and Australia have shown a relatively high burden of asthma and allergies amongst ethnic minority groups. The precise reasons underpinning the high disease burden are not well understood, but it is likely that this involves complex gene-environment interaction, behavioural and cultural elements. Poor clinical outcomes have been related to multiple factors including access to health care, engagement with healthcare professionals and concordance with advice which are affected by deprivation, literacy, cultural norms and health beliefs. It is unclear at present if allergic conditions are intrinsically more severe amongst patients from ethnic minority groups. Most evidence shaping our understanding of disease pathogenesis and clinical management is biased towards data generated from white population resident in high-income countries. In conjunction with standards of care, it is prudent that a multi-pronged approach towards provision of composite, culturally tailored, supportive interventions targeting demographic variables at the individual level is needed, but this requires further research and validation. In this narrative review, we provide an overview of epidemiology, sensitization patterns, poor clinical outcomes and possible factors underpinning these observations and highlight priority areas for research.

Indexed as

AsthmaCOVID-19Developed CountriesEthnic and Racial MinoritiesEthnicityHumansMinority GroupsPandemics

Identifiers

PMID35306712
PMCPMC9324921
OpenAlexW4220652699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.